Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.49 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1425186 | 0.95 | KDM4E (0.52) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL18639265 | 0.93 | KDM4E (0.53) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL29594018 | 0.93 | KDM4E (0.53) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL285479 | 0.93 | KDM4E (0.53) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL24198978 | 0.93 | KDM4E (0.53) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL24514268 | 0.93 | KDM4E (0.53) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL1485904 | 0.93 | KDM4E (0.53) | CARM1PRMT6MAPTGAALMNA | |
| Hydrochloric Acid SCHEMBL11683673 | 0.93 | GAA (0.50) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL10480342 | 0.93 | KDM4E (0.53) | CARM1PRMT6MAPTGAALMNA | |
| SCHEMBL17822020 | 0.93 | GAA (0.50) | CARM1PRMT6MAPTGAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322132-B | N-substituted indole compound and synthesis method thereof | 陕西科技大学 | 2024-05-28 | — | — | CN | claimed |
| CN-115322132-A | N-substituted indole compound and synthetic method thereof | 陕西科技大学 | 2022-11-11 | — | — | CN | claimed |
| EP-2261203-B1 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARING PROCESSES AND THE USES THEREOF | BEIJING YINGU CENTURY PHARMACY CO LTD (CN) | 2016-05-25 | — | — | EP | claimed |
| US-8673981-B2 | Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof | YinGu Pharmaceutical Co., Ltd (CN) | 2014-03-18 | — | — | US | claimed |
| US-20130289124-A1 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARATION PROCESSES AND USES THEREOF | YinGu Pharmaceutical Co., Ltd (CN) | 2013-10-31 | — | — | US | claimed |
| US-8497305-B2 | Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof | YinGu Pharmaceutical Co., Ltd (CN) | 2013-07-30 | — | — | US | claimed |
| US-20110224305-A1 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARATION PROCESSES AND USES THEREOF | BEIJING YINGU CENTURY PHARMACY CO. LTD (CN) | 2011-09-15 | — | — | US | claimed |
| EP-2318363-A1 | HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS | Nuevolution A/S (DK) | 2011-05-11 | — | — | EP | claimed |
| EP-2261203-A1 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARING PROCESSES AND THE USES THEREOF | Beijing Cachet Biomedical Co., Ltd (CN) | 2010-12-15 | — | — | EP | claimed |
| WO-2009152824-A1 | HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS | NUEVOLUTION A/S (DK) | 2009-12-23 | — | — | WO | claimed |
| EP-4610285-A1 | RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-09-03 | — | — | EP | disclosed |
| EP-4610287-A1 | RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-20250236723-A1 | RESIN SHEET, LAMINATED BOARD, METAL-CLAD LAMINATED BOARD, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | RESONAC CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| CN-120092029-A | Resin composition, cured product, prepreg, metal foil-clad laminate, resin composite sheet, and printed wiring board | 三菱瓦斯化学株式会社 | 2025-06-03 | — | — | CN | disclosed |
| CN-119899377-A | Polymaleimide compound, curable composition, cured product, prepreg, circuit board, laminate film, semiconductor sealing material, and semiconductor device | DIC株式会社 | 2025-04-29 | — | — | CN | disclosed |
| WO-2009124458-A1 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARING PROCESSES AND THE USES THEREOF | 北京嘉事堂生物医药有限公司 (CN) | 2009-10-15 | — | — | WO | disclosed |
| EP-0900237-B1 | PHOTOACTIVE COMPOUNDS FOR USE WITH NARROW WAVELENGTH BAND ULTRAVIOLET (UV) CURING SYSTEMS | ALBEMARLE CORP (US) | 2002-10-09 | — | — | EP | disclosed |
| US-6140385-A | USING A LESSER AMOUNT OF PHOTOINITIATOR AND NO SYNERGIST WHEN PHOTOPOLYMERIZING AN UNSATURATED COMPOUND, E.G., (METH)ACRYLATE; IRRADIATION WITH ULTRAVIOLET LIGHT OF WAVELENGTH OF 200-450 NM OR VISIBLE LIGHT | FIRST CHEMICAL CORPORATION (US) | 2000-10-31 | — | — | US | disclosed |
| EP-0900237-A1 | PHOTOACTIVE COMPOUNDS FOR USE WITH NARROW WAVELENGTH BAND ULTRAVIOLET (UV) CURING SYSTEMS | First Chemical Corporation (US) | 1999-03-10 | — | — | EP | disclosed |
| WO-1997044364-A1 | PHOTOACTIVE COMPOUNDS FOR USE WITH NARROW WAVELENGTH BAND ULTRAVIOLET (UV) CURING SYSTEMS | FIRST CHEMICAL CORPORATION (US) | 1997-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224305-A1 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARATION PROCESSES AND USES THEREOF | AADAC, WIZ, CEBPZ | CARM1 666/4885PRMT6 1521/4885MAPT 1887/4885 |
| US-20130289124-A1 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARATION PROCESSES AND USES THEREOF | AADAC, WIZ, CEBPZ | CARM1 666/4885PRMT6 1521/4885MAPT 1887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.